Search
for
Sort by
Research 30 of 298
- Hypoactive Sexual Desire and Other Sexual Dysfunctions Caused by Side Effects of Medicines Used to Treat Various Somatic Diseases and for Contraception
- Sexual dysfunction, including hypoactive sexual desire disorder: Diagnosis and treatment recommendations
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Endocrine Aspects of Female Sexual Dysfunction
- Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis
- Female sexuality and common sexual dysfunctions: evaluation and management in a primary care setting
- Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction.
- Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen: A Phase III Research Study of Female Sexual Dysfunction in Women on Testosterone Patch Without Estrogen (APHRODITE)
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- Changes of androgens levels in menopausal women
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Androgen Therapy in Women: A Reappraisal: An Endocrine Society Clinical Practice Guideline
- The Neurobiology of Sexual Function
- To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application
- 104 Flibanserin Subset Analyses and the Androgenics of Hypoactive Sexual Desire Disorder
- The clinical management of testosterone replacement therapy in postmenopausal women with hypoactive sexual desire disorder: a review
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women
- Sexual Dysfunction Related to Drugs: a Critical Review. Part V: α-Blocker and 5-ARI Drugs
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- FDA-Approved (Bremelanotide, Flibanserin) and Off-Label Medications (Testosterone, Sildenafil) to Enhance Sexual Desire/Function in Women
- Androgen treatment of postmenopausal women
- The Safety of Testosterone Therapy in Women
- The Role of Androgens in Health and Disease in Females: A Narratıve Review
- REPORTS: Summary of the Recommendations on Sexual Dysfunctions in Women
- Impact of Hormones on Female Sexual Function and Dysfunction
- RETIRED: Managing Menopause Chapter 8 Sexuality and Menopause
- Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
- Sexual Dysfunction in Alopecia Areata: A Systematic Review